Position in SUPN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$558
-$62 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#312
of 331 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Torren Management, LLC holds $28,158 across 10 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
679 | $16,710 | |
| 2 | BIOA |
BioAge Labs, Inc.
|
213 | $5,220 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3 | $1,625 | |
| 4 | HROW |
Harrow, Inc.
|
31 | $1,316 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
137 | $1,148 | |
| 6 | ALKS |
Alkermes plc.
|
13 | $681 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
12 | $567 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
12 | $558 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558 | 12 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $620 | 12 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $49,004 | 986 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||